Form 4: Immunovant's Chief Technology Officer Sells Shares to Cover Tax Obligations

Jay S. Stout, Chief Technology Officer of Immunovant, Inc., sold 1,925 shares of common stock on April 23, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On April 23, 2025, Jay S. Stout, the Chief Technology Officer of Immunovant, Inc., sold 1,925 shares of common stock at a price of $14.79 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of 6,250 restricted stock units (RSUs) on April 17, 2025.
• These RSUs were part of a grant of 100,000 RSUs awarded on April 17, 2023.
• The sale was mandated by Immunovant's policy requiring tax obligations to be funded through a 'sell to cover' transaction.
• Following the transaction, Jay S. Stout beneficially owns 209,243 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock transactions by a company executive to cover tax obligations. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives and employees.

Stakeholder Impact

• The sale of shares by an executive could have a minor, short-term impact on shareholder sentiment.

Key Dates

Keywords

Immunovant, Jay S. Stout, Chief Technology Officer, Stock Sale, Form 4, RSUs, Tax Withholding, Beneficial Ownership